Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $522,004 - $932,511
-12,670 Closed
0 $0
Q3 2021

Oct 29, 2021

SELL
$59.15 - $91.99 $57,730 - $89,782
-976 Reduced 7.15%
12,670 $803,000
Q2 2021

Aug 11, 2021

SELL
$63.02 - $95.11 $30,942 - $46,699
-491 Reduced 3.47%
13,646 $1.25 Million
Q1 2021

May 11, 2021

SELL
$57.62 - $95.6 $167,443 - $277,813
-2,906 Reduced 17.05%
14,137 $963,000
Q4 2020

Feb 05, 2021

BUY
$41.43 - $77.09 $91,601 - $170,445
2,211 Added 14.91%
17,043 $1.24 Million
Q3 2020

Oct 30, 2020

BUY
$30.88 - $37.94 $5,620 - $6,905
182 Added 1.24%
14,832 $562,000
Q2 2020

Jul 22, 2020

BUY
$18.95 - $35.43 $26,681 - $49,885
1,408 Added 10.63%
14,650 $519,000
Q1 2020

May 14, 2020

SELL
$13.94 - $28.25 $17,871 - $36,216
-1,282 Reduced 8.83%
13,242 $289,000
Q4 2019

Feb 10, 2020

BUY
$19.24 - $28.41 $279,441 - $412,626
14,524 New
14,524 $313,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.